Teva Pharmaceutical reported 290M in Net Income for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Aspen Pharmacare APN:SJ 2.26B 292M
Cipla CIPLA:IN IR 7113.6M 33.6M
Dr.Reddys Laboratories DRRD:IN IR 9958M 6154M
Guangzhou Baiy 600332:CH CH 809.36M 65.6M
Jiangsu Hengrui Me. 600276:CH CH 1.54B 368.56M
Kalbe Farma Tbk Pt KLBF:IJ RI 790449.45M 9630.14M
Richter Gedeon RICHT:HB 38.19B 10.17B
Sh Fosun Pharma 600196:CH CH 1.08B 552.83M
Sun Pharmaceuticals SUNP:IN IR 20470.1M 6028.4M
Teva Pharmaceutical TEVA:IT 290M 83M